• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Lutonix Inc.

Medtech manufacturers must add warning label to drug-eluting PAD devices

June 16, 2020 By Nancy Crotti

UK medtech regulators on Monday announced that manufacturers of paclitaxel-eluting balloons for use in peripheral arteries must add a warning label about the devices’ risks. A meta-analysis published in the Journal of the American Heart Association in 2018 suggested that patients treated with paclitaxel-coated balloons and stents for peripheral artery disease could be at a higher risk for […]

Filed Under: Business/Financial News, Drug-Device Combinations, Drug-Eluting Stents, Featured, Regulatory/Compliance, Stents, Vascular Tagged With: B. Braun, Biosensors International Group Ltd., Biotronik, Boston Scientific, Cook Medical, FDA, Lutonix Inc., LVD Biotech, Medtronic, Spectranetics Corp., U.K.medicinesandhealthcareproductsregulatoryagency

Ex-Lutonix R&D veep Barry pleads guilty to trade secret theft

May 10, 2017 By Brad Perriello

The former vice president of R&D for drug-coated balloon maker Lutonix, Christopher Barry, yesterday pleaded guilty to a single count of trade secret theft in federal court in Minneapolis. Barry, who left Lutonix in 2015 to become CEO of Urotronic, admitted to downloading 6 files in April 2015 containing trade secrets about the development of […]

Filed Under: Drug-Device Combinations, Legal News Tagged With: C.R. Bard, Drug-Eluting Balloons, Lutonix Inc., urotronic

Bard touts 2-year data on Lutonix

June 19, 2015 By Fink Densford

C.R. Bard (NYSE:BCR) said that data from a 2-year study of its Lutonix drug-coated balloon catheter showed positive results for the device when compared to standard percutaneous transluminal angioplasty. The 2-year Levant study data showed non-inferiority of the device and a trend towards superiority compared to standard PTA, the company said. Composite safety scores at […]

Filed Under: Cardiovascular, Clinical Trials, Vascular Tagged With: C.R. Bard, Lutonix Inc.

TCT 2013: Is the Lutonix drug-coated balloon overblown? | MassDevice.com On Call

November 4, 2013 By Brad Perriello Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Six-month data from the Levant-2 trial of C.R. Bard‘s (NYSE:BCR) Lutonix drug-coated balloon for treating femoropopliteal artery disease came as a surprise for those hoping the device will be a breakthrough treatment for peripheral artery disease.

Filed Under: News Well Tagged With: C.R. Bard, Lutonix Inc., Peripheral, TCT 2013, Transcatheter Cardiovascular Therapeutics symposium (TCT)

C.R. Bard shifts jobs to upstate N.Y.

October 30, 2013 By Chris Walker Leave a Comment

C.R. Bard shifts jobs to upstate NY

C.R. Bard (NYSE:BCR) began adding jobs in its Queensbury, N.Y., facility, adding 30-40 positions after 2 rounds of layoffs last year.

Filed Under: News Well Tagged With: C.R. Bard, Flowcardia, Layoffs, Loma Vista Medical, Lutonix Inc.

Bard plans for Q4 PMA filing on Lutonix balloon

October 23, 2013 By Brad Perriello Leave a Comment

Bard plans for Q4 PMA filing on Lutonix balloon

C.R. Bard (NYSE:BCR) said it expects to file the final module in its pre-market approval application with the FDA for the Lutonix drug-eluting balloon after a clinical trial met its primary endpoints for efficacy and safety.

Filed Under: News Well Tagged With: C.R. Bard, Clinical Trials, Lutonix Inc., Peripheral

MassDevice.com +3 | Bard nabs Lutonix for $325M, Lugar warns against Chinese price controls, Tough times for Siemens means jobs cuts

December 21, 2011 By MassDevice Contributors Network Leave a Comment

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you’re still in the know with MassDevice +3.

Filed Under: News Well Tagged With: C.R. Bard, Layoffs, Lutonix Inc., Siemens, U.S. Senate

Bard nabs angioplasty balloon maker for $325 million | Acquisitions Roundup

December 21, 2011 By MassDevice staff Leave a Comment

C.R. Bard logo
Lutonix logo

C.R. Bard (NYSE:BCR) acquired Minneapolis-based angioplasty balloon maker Lutonix Inc. for $325 million.

The merger, announced during Bard’s 2012 guidance update conference call, grants Lutonix $225 million up front with another $100 million when Lutonix achieves pre-market approval for its drug-coated balloons.

Filed Under: News Well Tagged With: Abacus Transcriptions Inc., Acquisitions Roundup, C.R. Bard, Hunan Changsha Tiandiren Biotech Co., iMedX Inc., Lutonix Inc., Mindray Medical International Ltd.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy